Ignite Creation Date:
2025-12-24 @ 9:17 PM
Ignite Modification Date:
2026-03-30 @ 11:03 PM
Study NCT ID:
NCT02545504
Status:
COMPLETED
Last Update Posted:
2020-05-26
First Post:
2015-09-08
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Andecaliximab With mFOLFOX6 as First Line Treatment for Advanced Gastric or Gastroesophageal Junction Adenocarcinoma
Sponsor:
Gilead Sciences
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2015-10-13
Start Date Type:
ACTUAL
Primary Completion Date:
2019-05-15
Primary Completion Date Type:
ACTUAL
Completion Date:
2019-05-15
Completion Date Type:
ACTUAL
First Submit Date:
2015-09-08
First Submit QC Date:
None
Study First Post Date:
2015-09-10
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2020-04-15
Results First Submit QC Date:
None
Results First Post Date:
2020-04-28
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2020-05-11
Last Update Post Date:
2020-05-26
Last Update Post Date Type:
ACTUAL